Healthy Returns: Biotech IPOs heated up, but haven't fully recovered
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
Source: cnbc.com
Mike Perrone News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mike Perrone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mike Perrone Today - Breaking & Trending Today
Healthy Returns: J&J, Merck and Bristol Myers Squibb in the hot seat
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.
Source: cnbc.com
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.
Source: nbclosangeles.com
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for the Vision Pro headset.
Source: nbcconnecticut.com
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Fast-approaching patent expirations will take a bite out of revenues and put the industry’s top players in the hot seat over the next few years.
Source: nbcconnecticut.com